ALPA — Alpa Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSuper Stock

Annual income statement for Alpa Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	780	860	976	1,123	930
Cost of Revenue
Gross Profit	249	307	328	362	334
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	800	858	911	1,033	829
Operating Profit	-19.7	1.91	64.7	90	100
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	27.6	29.1	108	196	159
Provision for Income Taxes
Net Income After Taxes	10.1	18.5	72.5	141	126
Net Income Before Extraordinary Items
Net Income	10.1	18.5	72.5	141	126
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	10.1	18.5	72.5	141	126
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.481	0.881	3.44	6.7	5.98